SeaCrest Wealth Management’s Guardant Health GH Stock Holding History

SeaCrest Wealth Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,200	Closed	-$48K	–	962
2022 Q2	$48K	Buy	+1,200	New	+$59.5K	0.01%	1133
2022 Q1	–	Sell	-3,339	Closed	-$334K	–	731
2021 Q4	$334K	Sell	3,339 -1,980	-37%	-$205K	0.04%	477
2021 Q3	$665K	Sell	5,319 -974	-15%	-$116K	0.08%	259
2021 Q2	$782K	Sell	6,293 -349	-5%	-$46.9K	0.09%	232
2021 Q1	$1.01M	Sell	6,642 -1,378	-17%	-$208K	0.13%	171
2020 Q4	$1.03M	Sell	8,020 -2,164	-21%	-$249K	0.15%	150
2020 Q3	$1.14M	Sell	10,184 -4,727	-32%	-$432K	0.18%	119
2020 Q2	$1.21M	Sell	14,911 -1,643	-10%	-$132K	0.21%	103
2020 Q1	$1.15M	Buy	16,554 +5,987	+57%	+$459K	0.25%	88
2019 Q4	$826K	Buy	10,567 +675	+7%	+$48.6K	0.14%	171
2019 Q3	$631K	Buy	9,892 +220	+2%	+$19.4K	0.12%	215
2019 Q2	$835K	Buy	9,672 +3,932	+69%	+$300K	0.17%	142
2019 Q1	$440K	Buy	5,740 +4,965	+641%	+$275K	0.08%	262
2018 Q4	$29K	Buy	+775	New	+$28.6K	0.01%	1090

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

SeaCrest Wealth Management's GH Position: Q3 2022 in Review

SeaCrest Wealth Management sold out of Guardant Health (GH) in Q3 2022, closing a stake of 1,200 shares — an estimated $48K sold.

SeaCrest Wealth Management first reported a position in GH in Q4 2018 and held it in 14 quarters. The position peaked at $1.21M in Q2 2020. 328 funds tracked by Wall St. Rank hold GH as of Q3 2022.

SeaCrest Wealth Management reported no remaining Guardant Health position as of Q3 2022 after selling out during the quarter.
SeaCrest Wealth Management sold 1,200 Guardant Health shares in Q3 2022, an estimated $48K.
SeaCrest Wealth Management first reported a position in Guardant Health in Q4 2018 and held it in 14 quarters.
SeaCrest Wealth Management's Guardant Health position peaked at $1.21M in Q2 2020.
328 funds tracked by Wall St. Rank held Guardant Health as of Q3 2022.

Based on SeaCrest Wealth Management's 13F filing for Q3 2022, filed 15 Nov 2022.